These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis. Meyer M, Huaux F, Gavilanes X, van den Brûle S, Lebecque P, Lo Re S, Lison D, Scholte B, Wallemacq P, Leal T. Am J Respir Cell Mol Biol; 2009 Nov; 41(5):590-602. PubMed ID: 19244203 [Abstract] [Full Text] [Related]
3. Generation and characterization of murine alternatively activated macrophages. Weisser SB, McLarren KW, Kuroda E, Sly LM. Methods Mol Biol; 2013 Nov; 946():225-39. PubMed ID: 23179835 [Abstract] [Full Text] [Related]
4. Functional phenotype of macrophages depends on assay procedures. Chiang CS, Chen FH, Hong JH, Jiang PS, Huang HL, Wang CC, McBride WH. Int Immunol; 2008 Feb; 20(2):215-22. PubMed ID: 18096562 [Abstract] [Full Text] [Related]
5. Markers of macrophage differentiation in experimental silicosis. Misson P, van den Brûle S, Barbarin V, Lison D, Huaux F. J Leukoc Biol; 2004 Nov; 76(5):926-32. PubMed ID: 15292275 [Abstract] [Full Text] [Related]
6. Modulation of murine macrophage function by IL-13. Doherty TM, Kastelein R, Menon S, Andrade S, Coffman RL. J Immunol; 1993 Dec 15; 151(12):7151-60. PubMed ID: 7903102 [Abstract] [Full Text] [Related]
7. Biodegradable chitosan particles induce chemokine release and negligible arginase-1 activity compared to IL-4 in murine bone marrow-derived macrophages. Guzmán-Morales J, Ariganello MB, Hammami I, Thibault M, Jolicoeur M, Hoemann CD. Biochem Biophys Res Commun; 2011 Feb 25; 405(4):538-44. PubMed ID: 21256824 [Abstract] [Full Text] [Related]
8. Azithromycin alters macrophage phenotype and pulmonary compartmentalization during lung infection with Pseudomonas. Feola DJ, Garvy BA, Cory TJ, Birket SE, Hoy H, Hayes D, Murphy BS. Antimicrob Agents Chemother; 2010 Jun 25; 54(6):2437-47. PubMed ID: 20231397 [Abstract] [Full Text] [Related]
9. The role of titanium surface topography on J774A.1 macrophage inflammatory cytokines and nitric oxide production. Tan KS, Qian L, Rosado R, Flood PM, Cooper LF. Biomaterials; 2006 Oct 25; 27(30):5170-7. PubMed ID: 16808973 [Abstract] [Full Text] [Related]
10. Bis-(3-hydroxyphenyl) diselenide inhibits LPS-stimulated iNOS and COX-2 expression in RAW 264.7 macrophage cells through the NF-kappaB inactivation. Shin KM, Shen L, Park SJ, Jeong JH, Lee KT. J Pharm Pharmacol; 2009 Apr 25; 61(4):479-86. PubMed ID: 19298695 [Abstract] [Full Text] [Related]
11. COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin/+ mouse polyps. Nakanishi Y, Nakatsuji M, Seno H, Ishizu S, Akitake-Kawano R, Kanda K, Ueo T, Komekado H, Kawada M, Minami M, Chiba T. Carcinogenesis; 2011 Sep 25; 32(9):1333-9. PubMed ID: 21730361 [Abstract] [Full Text] [Related]
12. Effects of dexmedetomidine on regulating endotoxin-induced up-regulation of inflammatory molecules in murine macrophages. Lai YC, Tsai PS, Huang CJ. J Surg Res; 2009 Jun 15; 154(2):212-9. PubMed ID: 19181340 [Abstract] [Full Text] [Related]
13. Modulation of TNFalpha, IL-10 and IL-12p40 levels by a ceramide-1-phosphate analog, PCERA-1, in vivo and ex vivo in primary macrophages. Avni D, Goldsmith M, Ernst O, Mashiach R, Tuntland T, Meijler MM, Gray NS, Rosen H, Zor T. Immunol Lett; 2009 Mar 24; 123(1):1-8. PubMed ID: 19185589 [Abstract] [Full Text] [Related]
14. The molecular signature of oxidative metabolism and the mode of macrophage activation determine the shift from acute to chronic disease in experimental arthritis: critical role of interleukin-12p40. Takahashi N, de Jager VC, Glück A, Letzkus M, Hartmann N, Staedtler F, Ribeiro-Dias F, Heuvelmans-Jacobs M, van den Berg WB, Joosten LA. Arthritis Rheum; 2008 Nov 24; 58(11):3471-84. PubMed ID: 18975327 [Abstract] [Full Text] [Related]
15. Inhibition of inflammatory mediator secretion by (-)-DHMEQ in mouse bone marrow-derived macrophages. Suzuki E, Sugiyama C, Umezawa K. Biomed Pharmacother; 2009 Jun 24; 63(5):351-8. PubMed ID: 18635336 [Abstract] [Full Text] [Related]
16. Reduced nitric oxide production and iNOS mRNA expression in IFN-gamma-stimulated chicken macrophages transfected with iNOS siRNAs. Cheeseman JH, Lillehoj HS, Lamont SJ. Vet Immunol Immunopathol; 2008 Oct 15; 125(3-4):375-80. PubMed ID: 18586326 [Abstract] [Full Text] [Related]
17. Inhibitory effect of ZPDC glycoprotein on the expression of inflammation-related cytokines through p38 MAP kinase and JNK in lipopolysaccharide-stimulated RAW 264.7 cells. Lee SJ, Lim KT. Inflamm Res; 2009 Apr 15; 58(4):184-91. PubMed ID: 19214384 [Abstract] [Full Text] [Related]
18. In vitro anti-inflammatory effects of arctigenin, a lignan from Arctium lappa L., through inhibition on iNOS pathway. Zhao F, Wang L, Liu K. J Ethnopharmacol; 2009 Apr 21; 122(3):457-62. PubMed ID: 19429312 [Abstract] [Full Text] [Related]
19. Macrophage activation: classical versus alternative. Classen A, Lloberas J, Celada A. Methods Mol Biol; 2009 Apr 21; 531():29-43. PubMed ID: 19347309 [Abstract] [Full Text] [Related]
20. An in vitro test system for compounds that modulate human inflammatory macrophage polarization. Shiratori H, Feinweber C, Luckhardt S, Wallner N, Geisslinger G, Weigert A, Parnham MJ. Eur J Pharmacol; 2018 Aug 15; 833():328-338. PubMed ID: 29920284 [Abstract] [Full Text] [Related] Page: [Next] [New Search]